Cargando…
Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
Therapeutic drug monitoring (TDM) is a useful tool for optimising the use of anti-TNFα inhibitors in patients with inflammatory bowel diseases (IBDs). Recently, point-of-care methods for the quantification of drug levels and anti-drug antibodies (ADAs) have been developed to overcome the limitations...
Autores principales: | Cheli, Stefania, Savino, Diego, Penagini, Francesca, Zuccotti, Gianvincenzo, Zuin, Giovanna, Clementi, Emilio, Cattaneo, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386140/ https://www.ncbi.nlm.nih.gov/pubmed/37514022 http://dx.doi.org/10.3390/pharmaceutics15071834 |
Ejemplares similares
-
Inflammation and neurological adverse drugs reactions: a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis
por: Antoniazzi, Stefania, et al.
Publicado: (2012) -
Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review
por: Penagini, Francesca, et al.
Publicado: (2016) -
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
por: Montrasio, Cristina, et al.
Publicado: (2023) -
LightSNiP assay is a good strategy for pharmacogenetics test
por: Cheli, Stefania, et al.
Publicado: (2015) -
Age-adjusted d-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021)